As of 2026-06-18, the Relative Valuation of Knight Therapeutics Inc (GUD.TO) is 0.87 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 9.29 CAD, the upside of Knight Therapeutics Inc based on Relative Valuation is -90.6%.
The range of the Relative Valuation is 0.70 - 2.56 CAD.
| Range | Selected | |
| Trailing P/E multiples | 12.3x - 44.8x | 15.3x |
| Forward P/E multiples | 14.6x - 53.6x | 18.3x |
| Fair Price | 0.70 - 2.56 | 0.87 |
| Upside | -92.5% - -72.5% | -90.6% |
| Date | P/E |
| 2026-06-09 | 161.19 |
| 2026-06-08 | 160.14 |
| 2026-06-05 | 150.85 |
| 2026-06-04 | 148.22 |
| 2026-06-03 | 145.60 |
| 2026-06-02 | 143.67 |
| 2026-06-01 | 144.37 |
| 2026-05-29 | 143.49 |
| 2026-05-28 | 139.29 |
| 2026-05-27 | 141.04 |
| 2026-05-26 | 142.97 |
| 2026-05-25 | 146.47 |
| 2026-05-22 | 146.30 |
| 2026-05-21 | 145.95 |
| 2026-05-20 | 143.32 |
| 2026-05-19 | 144.89 |
| 2026-05-15 | 147.70 |
| 2026-05-14 | 151.38 |
| 2026-05-13 | 148.75 |
| 2026-05-12 | 151.03 |
| 2026-05-11 | 151.73 |
| 2026-05-08 | 152.25 |
| 2026-05-07 | 146.30 |
| 2026-05-06 | 131.58 |
| 2026-05-05 | 132.28 |
| 2026-05-04 | 132.28 |
| 2026-05-01 | 132.28 |
| 2026-04-30 | 131.40 |
| 2026-04-29 | 130.53 |
| 2026-04-28 | 129.30 |
| 2026-04-27 | 131.93 |
| 2026-04-24 | 132.10 |
| 2026-04-23 | 130.70 |
| 2026-04-22 | 130.18 |
| 2026-04-21 | 130.00 |
| 2026-04-20 | 132.10 |
| 2026-04-17 | 134.03 |
| 2026-04-16 | 134.38 |
| 2026-04-15 | 135.61 |
| 2026-04-14 | 132.81 |
| 2026-04-13 | 133.51 |
| 2026-04-10 | 132.28 |
| 2026-04-09 | 134.03 |
| 2026-04-08 | 131.93 |
| 2026-04-07 | 134.03 |
| 2026-04-06 | 134.73 |
| 2026-04-02 | 130.53 |
| 2026-04-01 | 130.35 |
| 2026-03-31 | 129.83 |
| 2026-03-30 | 127.90 |